INFUSYSTEM HOLDINGS, INC Supplies Expense
INFUSYSTEM HOLDINGS, INC (INFU) reported Supplies Expense of $10.02 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SuppliesExpense · last filed 2026-08-04
- INFUSYSTEM HOLDINGS, INC supplies expense for the quarter ending 2026-06-30 was $10.02M, a 13.76% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC supplies expense for the quarter ending 2026-03-31 was $8.70M, a 6.06% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC supplies expense for the quarter ending 2025-12-31 was $9.28M, a 7.17% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC supplies expense for the quarter ending 2025-09-30 was $8.93M, a 2.06% increase year-over-year.
- INFUSYSTEM HOLDINGS, INC supplies expense for fiscal 2025 was $35.22M, a 0.77% increase from fiscal 2024.
- INFUSYSTEM HOLDINGS, INC supplies expense for fiscal 2024 was $34.95M, a 5.68% increase from fiscal 2023.
- INFUSYSTEM HOLDINGS, INC supplies expense for fiscal 2023 was $33.07M.
| Period end | Supplies Expense 3 month | Supplies Expense 6 month | Supplies Expense 9 month | Supplies Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $10.02M 10-Q · filed 2026-08-04 | $18.72M 10-Q · filed 2026-08-04 | $28.00M derived: sum of 3 quarters · filed 2026-08-04 | $36.93M derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $8.70M 10-Q · filed 2026-05-08 | $17.98M derived: sum of 2 quarters · filed 2026-05-08 | $26.91M derived: sum of 3 quarters · filed 2026-05-08 | $35.72M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $9.28M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $18.21M derived: sum of 2 quarters · filed 2026-02-27 | $27.02M derived: sum of 3 quarters · filed 2026-08-04 | $35.22M 10-K · filed 2026-02-27 |
| 2025-09-30 | $8.93M 10-Q · filed 2025-11-04 | $17.74M derived: sum of 2 quarters · filed 2026-08-04 | $25.94M 10-Q · filed 2025-11-04 | $34.60M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $8.81M 10-Q · filed 2026-08-04 | $17.01M 10-Q · filed 2026-08-04 | $25.67M derived: sum of 3 quarters · filed 2026-08-04 | $34.42M derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $8.20M 10-Q · filed 2026-05-08 | $16.86M derived: sum of 2 quarters · filed 2026-05-08 | $25.61M derived: sum of 3 quarters · filed 2026-05-08 | $34.38M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $8.66M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $17.41M derived: sum of 2 quarters · filed 2026-02-27 | $26.18M derived: sum of 3 quarters · filed 2026-02-27 | $34.95M 10-K · filed 2026-02-27 |
| 2024-09-30 | $8.75M 10-Q · filed 2025-11-04 | $17.52M derived: sum of 2 quarters · filed 2025-11-04 | $26.29M 10-Q · filed 2025-11-04 | |
| 2024-06-30 | $8.77M 10-Q · filed 2025-08-05 | $17.54M 10-Q · filed 2025-08-05 | ||
| 2024-03-31 | $8.77M 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $33.07M 10-K · filed 2025-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 |